In this study, we explored the feasibility of DNA methylation for detection of GCC, and established a new assay, the ColoCaller test, which combined the detection of SDC2, TFPI2, WIF1, and NDRG4 methylation, and evaluated its clinical performance for early detection of GCC. Here, NDRG4 is linked to goblet cell carcinoma.